ES531516A0 - Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona - Google Patents

Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona

Info

Publication number
ES531516A0
ES531516A0 ES531516A ES531516A ES531516A0 ES 531516 A0 ES531516 A0 ES 531516A0 ES 531516 A ES531516 A ES 531516A ES 531516 A ES531516 A ES 531516A ES 531516 A0 ES531516 A0 ES 531516A0
Authority
ES
Spain
Prior art keywords
espirox
ona
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531516A
Other languages
English (en)
Other versions
ES8602845A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES531516A0 publication Critical patent/ES531516A0/es
Publication of ES8602845A1 publication Critical patent/ES8602845A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES531516A 1983-04-13 1984-04-11 Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona Expired ES8602845A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH197983 1983-04-13

Publications (2)

Publication Number Publication Date
ES531516A0 true ES531516A0 (es) 1985-12-01
ES8602845A1 ES8602845A1 (es) 1985-12-01

Family

ID=4223075

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531516A Expired ES8602845A1 (es) 1983-04-13 1984-04-11 Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona

Country Status (6)

Country Link
US (1) US4552871A (es)
EP (1) EP0122882A1 (es)
JP (1) JPS59205400A (es)
AU (1) AU2685284A (es)
DK (1) DK189584A (es)
ES (1) ES8602845A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
KR20040080439A (ko) 2001-12-12 2004-09-18 파마시아 코포레이션 에폭시-스테로이드성 알도스테론 수용체 길항제에 의한안구 질환의 치료 방법
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1368731A (en) * 1972-01-24 1974-10-02 Searle & Co 9alpha 11alpha-epoxy spirolactones and corresponding spirolactols and lactol ethers
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
US4079054A (en) * 1976-12-22 1978-03-14 Schering Corporation 7α-Halogeno-3-oxo-1,4-pregnadiene-21,17β-carbolactones and related compounds

Also Published As

Publication number Publication date
DK189584D0 (da) 1984-04-12
EP0122882A1 (de) 1984-10-24
JPS59205400A (ja) 1984-11-20
DK189584A (da) 1984-10-14
ES8602845A1 (es) 1985-12-01
US4552871A (en) 1985-11-12
AU2685284A (en) 1984-10-18

Similar Documents

Publication Publication Date Title
ES536849A0 (es) Procedimiento para la obtencion de una composicion organopolisiloxanica.
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES553050A0 (es) Procedimiento para la obtencion de n-(piperidinil-alquil)-carboxamidas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES534539A0 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
ES535534A0 (es) Procedimiento para la obtencion de -aril-1h-azol-1-etanoles
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES532240A0 (es) Procedimiento para la obtencion de benzoil-ureas.
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES531516A0 (es) Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES534947A0 (es) Procedimiento para la obtencion de 2-(1-indolinil-metil)-imidazolinas
ES538806A0 (es) Procedimiento para la obtencion de nuevos 1,4-naftoquinonderivados
ES532635A0 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
ES534221A0 (es) Procedimiento para la obtencion de pirrolidinonas
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES535291A0 (es) Procedimiento para la obtencion de agentes termosensibilizadores
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas